The phase 1/2 study will assess next-generation immunotherapy alone and in combination with an immune checkpoint inhibitor in ...

This analysis provides much-needed robust data on the efficacy of heat-cold therapy for mitigating discomfort and insomnia in restless legs syndrome (RSL).

The global apheresis market was valued at $2.4 billion in 2021 and is projected to reach $5.3 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031.